Delivery of the Pertactin/P.69 polypeptide of Bordetella pertussis using an attenuated Salmonella typhimurium vaccine strain: Expression levels and immune response

Vaccine

Volumn 14, Issue 14, 1996, Pages 1384-1390

  Anderson, Richard ^a   Dougan, Gordon ^b   Roberts, Mark ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Bordetella pertussis; Oral vaccine; Pertactin P.69; Salmonella typhimurium

Indexed keywords

BACTERIAL VACCINE; PERTACTIN; POLYPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GENE EXPRESSION; INTRAVENOUS DRUG ADMINISTRATION; MICROBIAL ATTENUATION; MOLECULAR CLONING; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BORDETELLA PERTUSSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI PROTEINS; FEMALE; IMMUNITY, CELLULAR; MICE; MICE, INBRED BALB C; NITRITE REDUCTASES; SALMONELLA TYPHIMURIUM; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRULENCE FACTORS, BORDETELLA;

EID: 0030268022     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00036-9     Document Type: Article

References (30)

1. Muller, A.S., Leeuwenburg, J. and Pratt, D.S. Pertussis: epidemiology and control. Bull. WHO 1986, 64, 321
2. Rappuoli, R., Pizza, M., Podda, A., De Magistris, M.T. and Nencioni, L. Towards third generation whooping cough vaccines. Trends Biotechnol. 1991, 9, 232
3. Leininger, E., Roberts, M., Kenimer, J.G. et al. Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. Proc. Natl. Acad. Sci. USA 1991, 88, 345
4. Roberts, M., Fairweather, N.F., Leininger-zapata, E. et al. Construction and characterisation of Bordetella pertussis mutants lacking the vir-regulated P. 69 outer membrane protein. Mol. Microbiol. 1991, 5, 1393
5. Charles, I., Fairweather, N., Pickard, D. et al. Expression of the Bordetella pertussis P.69 pertactin adhesin in Escherichia coli: fate of the carboxy-terminal domain. Microbiology 1994, 140, 3301
6. Shahin, R.D., Brennan, M.J., Li, Z.M., Meade, B.D. and Manclark, C.R. Characterisation of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J. Exp. Med. 1990, 171, 63
7. Roberts, M., Tite, J.P., Fairweather, N.F., Dougan, Q. and Charles, I.G. Recombinant P.69/pertactin: immunogenicity and protection of mice against Bordetella pertussis infection. Vaccine 1992, 10, 43
8. Gamsin, S. and Chandler, A. Smithkline Beecham's new acellular pertussis vaccine demonstrateds enhanced efficacy in major niaid studies. Press release, 13 July 1995
9. Roberts, M., Chatfield, S.N., and Dougan, G. Salmonella as carriers of Heterologous Antigens. Novel Delivery Systems for Oral Vaccines (Ed. O'Hagan D.T.). CRC Press, Boca Raton, FL, 1994, pp. 27-58
10. Molina, N.C. and Parker, C.D. Murine antibody response to oral infection with live aroA recombinant Salmonella dublin vaccine strains expressing filamentous hemagglutinin antigen from Bordetella pertussis. Infect. Immun. 1990, 58, 2523
11. Guzman, C.A., Brownlie, R.M., Kadurugamuwa, J., Walker, M.J. and Timmis, K.N. Antibody responses in the lungs of mice following oral immunization with Salmonella typhimurium aroA and invasive Escherichia constrains expressing the filamentous hemagglutinin of Bordetella pertussis. Infect. Immun. 1991, 59, 4391
12. Walker, M.J., Rohde, M., Timmis, K.N. and Guzman, C.A. Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aroA, Salmonella typhi Ty21a, and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit. Infect. Immun. 1992, 60, 4260
13. Strugnell, R., Dougan, G., Chatfield, S. et al. Characterisation of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Infect. Immun. 1992, 60, 3994
14. Roberts, M., Cropley, I., Chatfield, S. and Dougan, G. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunisation with P.69 and FHA. Vaccine 1993, 11, 866
15. Redhead, K., Watkins, J., Barnard, A. and Mills, K.H.G. Effective immunisation against Bordetella pertussis respiratory infection is dependent on induction of cell-mediated immunity. Infect. Immun. 1993, 61, 3190
16. Collins, F.M. Vaccines and cell-mediated immunity. Bact. Rev. 1974, 38, 371
17. Chatfield, S.N., Charles, I.G., Makoff, A.J. et al. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Bio/Technology 1992, 10, 888
18. Makoff, A.J., Oxer, M.D., Ballintine, S.P., Fairweather, N.F. and Charles, I.G. Protective surface antigen P.69 of Bordetella pertussis: its characterisation and high level synthesis in Escherichia coli. Bio/Technology 1990, 8, 1030
19. Davis, R.W., Botstein, D. and Roth, J.R. Advanced Bacterial Genetics. A Manual for Genetic Engineering. Cold Spring Harbour Laboratory, Cold Spring Harbour, NY, 1980
20. Roberts, M., Masked, D., Novotny, P. and Dougan. G. Construction and characterisation in vivo of bordetella pertussis aroA mutants. Infect. Immun. 1990, 58, 732
21. Cohen, S.M. and Wheeler, M. Pertussis vaccine prepared from phase 1 cultures grown in fluid medium. Am. J. Publ. Hlth 1946, 36, 371
22. Charles, I.G., Li, J.L., Roberts, M. et al. Identification and characterisation of a protective immunodominant B cell epitope of pertactin (P.69) from Bordetella pertussis. Eur. J. Immun. 1991, 21, 1147
23. Maskell, D.U., Sweeney, K.J., O'Callaghan, D., Hormaeche, C.E., Liew, F.Y. and Dougan, G. Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat labile entero-toxin B subunit to the murine systemic and secretory immune systems. Microbiol. Pathog. 1987, 3, 129
24. Tite, J.P., Russell, S.M., Dougan, G. et al. Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. I. Characteristics and cross-reactivity of T-cell responses. J. Immun. 1988, 141, 3980
25. Romanos, M.A., Clare, J.J., Beesley, K.M. et al. Recombinant Bordetella pertussis pertactin (P.69) from the yeast Pichia pastoris: high level production and immunological properties. Vaccine 1991, 9, 901
26. Villarreal, B., Masroeni, P., Demarco de Hormaeche, R. and Hormaeche, C.E. Proliferative and T-cell specific interleukin (IL-2/IL-4) production responses in spleen cells from mice vaccinated with aroA live attenuated Salmonella vaccines. Microbial. Pathogenesis 1992, 13, 305
27. Oxer, M.D., Bently, C.M., Doyle, J.G., Peakman, T.C., Chartes, I.G. and Makoff, A.J. High level heterologous expression in E. coli using the anaerobically-activated nirB promoter. Nucleic. Acids Res. 1991, 19, 1889
28. Everest, P., Frankel, G., Li, J., Lund, P., Chatfield, S. and Dougan, G. Expression of lacZ from nirB, groE and htrA promoters: influence of growth inside mammalian cells. FEMS Microbiol. Lett. 1995, 126, 97
29. Bullas, L.R. and Ryu, J.I. Salmonella typhimurium LT2 strains which are r-m+ for all three chromosomaiiy located systems of DNA restriction and modification. J. Bacteriol. 1983, 156, 471
30. Coffman, R.L., Seymour, B.W.P., Lebman, D.A. et al. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immun. Rev. 1988, 102, 5